Protein losses during peritoneal dialysis
نویسندگان
چکیده
منابع مشابه
Prevention of amino acid losses during peritoneal dialysis.
The addition of amino acid supplements to peritoneal dialysis fluid has been studied in 8 patients with compromised renal function requiring peritoneal dialysis. By the addition of 10 ml of Vamin-glucose solution to each one litre of peritoneal dialysate, amino acid losses were curtailed, no significant alterations occurred in the plasma amino acid concentrations, there were no local complicati...
متن کاملPeritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients.
BACKGROUND AND OBJECTIVES Peritoneal clearance of albumin-unlike the transport of small molecules-is defined by both vascular surface area and size-selective permeability. Few studies have supported a positive correlation between peritoneal albumin loss and mortality. The aim of this study was to investigate whether baseline peritoneal loss and clearance of albumin and other proteins is a risk ...
متن کاملPeritoneal Dialysis
La,dialyse peritoneale constitue une methode d,epuration extra-renale simple,efficqCe et d,un prix de revient modere. La dialyse peritoneale,ne necestite aueuneinstalation complexe,peut-etre consideree comme une methode de reanimation non specialisedont la vulgarosation doit permettre: De traiter surplace d,une maniere intensive et prophylactique les nombreuses insuffisances renales aiPue...
متن کاملOutput of peritoneal cells during peritoneal dialysis.
Peritoneal dialysis provides a good source for the collection of macrophages. Six patients with chronic renal failure undergoing peritoneal dialysis for the first time were studied, and maximum cell egress, mostly macrophages, occurred at 24-48 hours and diminished after 48 hours.
متن کاملMexiletine clearance during peritoneal dialysis.
infant would receive approximately 1.5 mg of disopyramide per day assuming a generous intake of 1 1 of milk. Even taking into account the two fold variability in breast milk levels of disopyramide reported by Barnett et al. (1980), the maximum amount of drug transmitted to the infant would be 3 mg/day (0.6% of the maternal dose). The manufacturer's product information recommends, on the basis o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 1981
ISSN: 0085-2538
DOI: 10.1038/ki.1981.57